Blog
RSS FeedPosted by Michael Wonder on 07 Dec 2024
Biden-Harris Administration takes next steps to increase access to sickle cell disease treatments
4 December 2024 - Today, the Biden-Harris Administration announced that two drug manufacturers with FDA approved gene therapies for sickle ...
Posted by Michael Wonder on 06 Dec 2024
NICE describes how weight loss drug tirzepatide will be rolled out
5 December 2024 - The medication will initially be offered only to those people with the highest clinical needs. ...
Posted by Michael Wonder on 06 Dec 2024
Jessica Lawrence’s meds cost her family $75k a year because they’re not listed on the PBS
6 November 2024 - Medications that are subsidised for cancer sufferers are critical to Jess Lawrence’s wellbeing, but because the 25-year-old ...
Posted by Michael Wonder on 06 Dec 2024
Government of Canada signs bilateral agreement with Alberta to improve access to drugs for rare diseases
5 December 2024 - Today, the Honourable Mark Holland, Canada's Minister of Health, and the Honourable Adriana LaGrange, Alberta's Minister ...
Posted by Michael Wonder on 05 Dec 2024
PHARMAC funds more cancer and respiratory medicines for New Zealanders
6 December 2024 - More publicly funded medicines are on the way for people with types of breast and lung ...
Posted by Michael Wonder on 03 Dec 2024
New Zealand Pharmaceutical Schedule - 1 December 2024
1 December 2024 - The December 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Dec 2024
Schedule of Pharmaceutical Benefits - 1 December 2024
1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Dec 2024
Life changing endometriosis treatment now cheaper
1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...
Posted by Michael Wonder on 01 Dec 2024
Voters clamour for affordable health in election lead-up
30 November 2024 - Threats and delays to affordable medicine access underscore an appetite for higher health spending, with polling placing ...
Posted by Michael Wonder on 01 Dec 2024
BC man calls on federal, provincial governments to cover his costly, life saving cancer treatment
30 November 2024 - Pharmaceutical company Novartis says a five dose treatment costs about $135K. ...
Posted by Michael Wonder on 27 Nov 2024
Australians benefit from new and expanded medicines on the PBS
20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...
Posted by Michael Wonder on 27 Nov 2024
Lilly Canada remains steadfast in commitment to access options for patients amidst controversial CDA-AMC recommendation for Ebglyss (lebrikizumab)
19 November 2024 - Eli Lilly Canada is disappointed and strongly disagrees with Canada's Drug Agency (CDA-AMC)'s Final Recommendation for Ebglyss ...
Posted by Michael Wonder on 16 Nov 2024
Novartis Canada disappointed with outcome of pCPA negotiations for metastatic castration resistant prostate cancer treatment Pluvicto
15 November 2024 - Novartis Canada is extremely disappointed that negotiations for Pluvicto (lutetium (Lu 177 ) vipivotide tetraxetan injection), ...
Posted by Michael Wonder on 14 Nov 2024
Qalsody: HAS update
8 November 2024 - On 10 October, the High Authority for Health (HAS) issued a negative decision on the request for ...
Posted by Michael Wonder on 12 Nov 2024
New heart medicine for 18,000 New Zealanders
12 November 2024 - PHARMAC has decided to fund the medicine empagliflozin for thousands of people with a type of ...